02197.HK香港交易所 · 主板 MainBPre-revenue biotech (Listing Rules ch.18A)
Clover Bio 三葉草生物
Pharmaceuticals and Biotechnology 药品及生物科技
HK$2.04−HK$0.02 · −0.73%
Open 开盘
HK$2.02
High 最高
HK$2.05
Low 最低
HK$2.00
Prev Close 昨收
HK$2.06
Volume 成交量
212.0万股
Turnover 成交额
HK$427.8万
Mkt Cap 总市值
HK$27亿
P/E 市盈率
−11.7×
Recent Activity 近期动态All Filings 全部公告 →
No significant filings since 30 May 2026.
自 30 May 2026 起无重大公告。
1.501.752.002.252.502.753.00
Volume 成交量
7,751.1万
Sep 25Dec 25Mar 26Jun 26Sep 26
Substantial Shareholders 主要股东
Interests of 5% or more disclosed to HKEX under Part XV of the SFO · 10 largest of 13 · Stake as % of issued voting shares of the class 该类别已发行有投票权股份
Several holders often report the same shares, so the stakes do not add up.
22.09%
20.24%
Hillhouse Investment Management, Ltd.
Institution 机构
1.65亿股 · As of 截至 13 Dec 2022
12.73%
Temasek Capital (Private) Limited
Institution 机构
1.10亿股 · As of 截至 5 Nov 2021
9.53%
Seletar Investments Pte Ltd
Institution 机构
1.10亿股 · As of 截至 5 Nov 2021
9.53%
Aranda Investments Pte. Ltd.
Institution 机构
1.10亿股 · As of 截至 5 Nov 2021
9.53%
JNRY V Holdings Limited
Institution 机构
9,379.6万股 · As of 截至 13 Dec 2022
7.26%
上海天合生泰企业管理合伙企业（有限合伙）
Institution 机构
7,000.0万股 · As of 截至 5 Nov 2021
6.04%
Hillhouse Fund IV, L.P.
Institution 机构
7,079.7万股 · As of 截至 13 Dec 2022
5.48%
HH IMV Holdings, L.P.
Institution 机构
7,079.7万股 · As of 截至 13 Dec 2022
5.48%